cyclosporine ophthalmic emulsion 0.05%

DRUG3 trials

Sponsors

Allergan, Boston Sight

Conditions

Dry Eye DiseaseOcular Surface DiseasePterygium

Phase 2

Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

CompletedNCT01109056

AllerganPterygium

Start: 2010-06-30End: 2011-06-30Updated: 2012-06-25

Phase 3

Novel Use of Restasis and PROSE Devices

WithdrawnNCT04735510

Boston SightOcular Surface Disease

Start: 2021-05-31End: 2021-09-30Updated: 2023-04-19

Unknown Phase

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

CompletedNCT00827255

AllerganDry Eye Disease

Start: 2009-01-31End: 2009-10-31Updated: 2019-04-25